Related Experiment Video
Updated: Dec 17, 2025

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
The Role of Revascularization in Chronic Stable Angina: Do We Have an Answer?
1Internal Medicine, University of Maryland Medical Center, Baltimore, USA.
Insights
Revascularization benefits acute coronary syndrome patients but its role in chronic stable angina remains debated. Optimal management for stable angina involves medical therapy and risk factor control, with revascularization
Area of Science:
- Cardiology
- Cardiovascular Medicine
Background:
- Coronary artery disease (CAD) is a major cause of mortality in the United States.
- Revascularization is proven to reduce death and re-infarction in acute coronary syndrome (ACS).
- Optimal management for chronic stable angina (CSA) is less defined compared to ACS.
Abstract:
Coronary artery disease is one of the leading causes of death in the United States. The utility of revascularization in patients presenting with acute coronary syndrome is well elucidated, both in reducing death and re-infarction. However, in patients with chronic stable angina, the optimal management strategy is less clear. While medical management with aggressive control of risk factors and lifestyle changes are the cornerstones of treatment, the utility of revascularization in this subset of patients has always been a topic of debate.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Angina IV: Management
Angina V: Nursing Management
Angina II: Classification
Peripheral Artery Disease III: Interprofessional Care
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...

